MindImmune Therapeutics Inc.

https://www.mindimmune.com

MindImmune is a biotech company targeting the immune system to treat brain disease. The company was founded in 2016 in the US and is based at the University of Rhode Island. It is affiliated with the George & Anne Ryan Institute for Neuroscience, a multidisciplinary research center focused on discovering and developing disease-modifying therapies for neurodegenerative disorders. *

	Start	2016-01-01 established
	Industry	CNS drug (neurological drug)
	Industry 2	drug development

	City	n. a. Kingston, RI
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«: H. Lundbeck A/S. (5/22/18). "Press Release: Lundbeck Divests Preclinical Research Programs. Two Programs Outside Lundbeck's Areas of Focus Are Transferred to MindImmune Therapeutics, Inc.". Valby.

		Record changed: 2023-07-10

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for MindImmune Therapeutics Inc.

[1] H. Lundbeck A/S. (5/22/18). "Press Release: Lundbeck Divests Preclinical Research Programs. Two Programs Outside Lundbeck's Areas of Focus Are Transferred to MindImmune Therapeutics, Inc.". Valby....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]